Literature DB >> 10405007

Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy.

H Louagie1, M Van Eijkeren, J Philippe, H Thierens, L de Ridder.   

Abstract

PURPOSE: To investigate the changes in peripheral blood lymphocyte subpopulations in patients undergoing radiotherapy.
MATERIALS AND METHODS: In 8 patients undergoing external beam radiotherapy to the pelvis, the different lymphocyte subpopulations were followed during treatment. The lymphocyte populations were determined using two-colour flow cytometry. The study comprises the T-helper, T-suppressor/cytotoxic cells, the B-lymphocytes and natural killer (NK) cells.
RESULTS: The B-cells were characterized by a steep decrease at the beginning of the radiotherapy. They reached their lowest level at an equivalent total body dose of approximately 1.5 Gy and remained constant during the rest of the therapy (10% of the initial level). In T-cells (both T-helper and T-suppressor subsets) the steep decrease was less pronounced. T-lymphocytes reached a base level at 2.5 Gy equivalent total body dose (20% of the initial level). No significant differences between the T-helper and the T-suppressor/cytotoxic cells were observed. NK cells were characterized by a weak decline during the first weeks of therapy, being less pronounced than in the other populations. Near the end of therapy, the NK cells reached the level of the T-lymphocytes.
CONCLUSION: In vivo, NK cells were the most radioresistant and B-cells the most radiosensitive lymphocytes. No significant differences between T-helper and T-suppressor/cytotoxic cells were observed. These data are in agreement with the differences in apoptosis induction in peripheral blood lymphocyte subpopulations after in vitro gamma-irradiation of whole blood lymphocytes.

Entities:  

Mesh:

Year:  1999        PMID: 10405007     DOI: 10.1080/095530099140113

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  11 in total

1.  The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.

Authors:  Ani Balmanoukian; Xiaobu Ye; Joseph Herman; Daniel Laheru; Stuart A Grossman
Journal:  Cancer Invest       Date:  2012-07-19       Impact factor: 2.176

2.  Hypersensitivity to chemoradiation in FANCA carrier with cervical carcinoma-A case report and review of the literature.

Authors:  Igor Sirák; Zuzana Šinkorová; Mária Šenkeříková; Jiří Špaček; Jan Laco; Hana Vošmiková; Stanislav John; Jiří Petera
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-05

3.  Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment.

Authors:  Fiorella D'Auria; Teodora Statuto; Luciana Rago; Antonietta Montagna; Giovanni Castaldo; Irene Schirò; Anna Zeccola; Teresa Virgilio; Gabriella Bianchino; Antonio Traficante; Alessandro Sgambato; Vincenzo Fusco; Luciana Valvano; Giovanni Calice
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

4.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

5.  Radiation-induced DNA damage and repair in human gammadelta and alphabeta T-lymphocytes analysed by the alkaline comet assay.

Authors:  Halina Lisowska; Marta Deperas-Kaminska; Siamak Haghdoost; Ingela Parmryd; Andrzej Wojcik
Journal:  Genome Integr       Date:  2010-06-08

6.  A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies.

Authors:  Stephen Shibata; Andrew Raubitschek; Lucille Leong; Marianna Koczywas; Lawrence Williams; Jiping Zhan; Jeffrey Y C Wong
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

7.  The effect of in vitro gamma-irradiation on mitogenic responsiveness of murine lymphocytes.

Authors:  J Hernández-Godoy; D Planelles; B Balsalobre; A González-Molina
Journal:  J Physiol Biochem       Date:  2008-09       Impact factor: 4.158

8.  Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.

Authors:  Keri L Calkins; Geetanjali Chander; Corinne E Joshu; Kala Visvanathan; Anthony T Fojo; Catherine R Lesko; Richard D Moore; Bryan Lau
Journal:  JAMA Oncol       Date:  2020-02-01       Impact factor: 31.777

9.  Factors influencing heterogeneity of radiation-induced DNA-damage measured by the alkaline comet assay.

Authors:  Clemens Seidel; Christine Lautenschläger; Jürgen Dunst; Arndt-Christian Müller
Journal:  Radiat Oncol       Date:  2012-04-20       Impact factor: 3.481

10.  Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System.

Authors:  Sylvia E Falcke; Paul F Rühle; Lisa Deloch; Rainer Fietkau; Benjamin Frey; Udo S Gaipl
Journal:  Int J Mol Sci       Date:  2018-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.